Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptide
PALLD
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5673466
Quick Overview for Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptide (ABIN5673466)
Target
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- RRPRSRSRDS GDENEPIQER FFRPHFLQAP GDLTVQEGKL CRMDCKVSGL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Background
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: MYN, PNCA1, CGI151, SIH002, CGI-151
Protein Size: 777 -
Gene ID
- 23022
-
NCBI Accession
- NM_001166108, NP_001159580
Target
-
You are here:
